GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hospira Inc (FRA:HOS) » Definitions » E10

Hospira (FRA:HOS) E10 : €0.00 (As of Jun. 2015)


View and export this data going back to . Start your Free Trial

What is Hospira E10?

Note: As E10 is a main component used to calculate Shiller PE Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation sectione below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hospira's adjusted earnings per share data for the three months ended in Jun. 2015 was €0.731. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Jun. 2015.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-10), Hospira's current stock price is €80.81. Hospira's E10 for the quarter that ended in Jun. 2015 was €0.00. Hospira's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Hospira was 65.01. The lowest was 18.44. And the median was 31.64.


Hospira E10 Historical Data

The historical data trend for Hospira's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hospira E10 Chart

Hospira Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.37 1.20 1.04 0.87 0.97

Hospira Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 1.00 0.97 0.98 -

Competitive Comparison of Hospira's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Hospira's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hospira's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hospira's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hospira's Shiller PE Ratio falls into.



Hospira E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hospira's adjusted earnings per share data for the three months ended in Jun. 2015 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2015 (Change)*Current CPI (Jun. 2015)
=0.731/100.6839*100.6839
=0.731

Current CPI (Jun. 2015) = 100.6839.

Hospira Quarterly Data

per share eps CPI Adj_EPS
200509 0.302 83.876 0.363
200512 0.137 83.032 0.166
200603 0.407 84.298 0.486
200606 0.269 85.606 0.316
200609 0.275 85.606 0.323
200612 0.227 85.142 0.268
200703 -0.143 86.640 -0.166
200706 0.149 87.906 0.171
200709 0.266 87.964 0.304
200712 0.322 88.616 0.366
200803 0.264 90.090 0.295
200806 0.276 92.320 0.301
200809 0.355 92.307 0.387
200812 0.481 88.697 0.546
200903 0.789 89.744 0.885
200906 0.114 91.003 0.126
200909 0.487 91.120 0.538
200912 0.400 91.111 0.442
201003 0.619 91.821 0.679
201006 0.401 91.962 0.439
201009 0.320 92.162 0.350
201012 0.269 92.474 0.293
201103 0.627 94.283 0.670
201106 0.590 95.235 0.624
201109 -0.393 95.727 -0.413
201112 -0.988 95.213 -1.045
201203 0.182 96.783 0.189
201206 -0.016 96.819 -0.017
201209 0.008 97.633 0.008
201212 0.024 96.871 0.025
201303 -0.355 98.209 -0.364
201306 0.152 98.518 0.155
201309 0.007 98.790 0.007
201312 0.147 98.326 0.151
201403 0.289 99.695 0.292
201406 0.309 100.560 0.309
201409 0.714 100.428 0.716
201412 0.168 99.070 0.171
201503 0.397 99.621 0.401
201506 0.731 100.684 0.731

Add all the adjusted EPS together and divide 10 will get our e10.


Hospira  (FRA:HOS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Hospira was 65.01. The lowest was 18.44. And the median was 31.64.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hospira E10 Related Terms

Thank you for viewing the detailed overview of Hospira's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Hospira (FRA:HOS) Business Description

Traded in Other Exchanges
N/A
Address
Hospira Inc was incorporated in Delaware on September 16, 2003. The Company is a provider of injectable drugs and infusion technologies, and is also engaged in developing, manufacturing, marketing and distribution. Its portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. The Company's business segments are Specialty Injectable Pharmaceuticals, Medication Management and Other Pharmaceuticals. Specialty Injectable Pharmaceuticals consists of generic injectable pharmaceuticals products. Generic injectable pharmaceuticals provide customers with a lower-cost alternative to branded products when associated patent protection expires, when patents are declared invalid, or when the generic products do not infringe the patents of others. Our generic injectable pharmaceuticals are sold in therapeutic areas including analgesia, anesthesia, anti-infectives, cardiovascular, oncology, and other. Medication Management offer the Hospira MedNet safety software system, which is designed for hospitals to customize intravenous drug dosage limits and track drug delivery to prevent medication errors. The wireless network version of the Hospira MedNet system establishes real-time send-and-receive capability and can interface with select hospital and pharmacy information systems. Other Pharmaceuticals primarily consists of large volume I.V. solutions, nutritionals and contract manufacturing services. We offer infusion therapy solutions and related supplies that include I.V. solutions for general use, I.V. nutrition products, and solutions for washing and cleansing of wounds or surgical sites. The Company's primary customers include hospitals, wholesalers, integrated delivery networks and alternate site facilities. Its competitors include Baxter International Inc.; Becton, Dickinson and Company; Fresenius Kabi AG; Mallinckrodt plc; Mylan Inc; Par Pharmaceuticals Companies, Inc.; Pfizer Inc.; Sandoz; Sanofi S.A. and Teva Pharmaceuticals, Aspen Medical; Fresenius Kabi; Pfizer; Sandoz and a number of smaller competitors and the originator companies. The Company's operations and business activities are subject to extensive legal and regulatory requirements that are enforced by numerous governmental agencies in the countries in which it do business.

Hospira (FRA:HOS) Headlines

No Headlines